Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.

Lobo M, Balouz V, Melli L, Carlevaro G, Cortina ME, Cámara MLM, Cánepa GE, Carmona SJ, Altcheh J, Campetella O, Ciocchini AE, Agüero F, Mucci J, Buscaglia CA.

PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007245. doi: 10.1371/journal.pntd.0007245. [Epub ahead of print]

2.

Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole.

Ruiz-Lancheros E, Rasoolizadeh A, Chatelain E, Garcia-Bournissen F, Moroni S, Moscatelli G, Altcheh J, Ndao M.

Open Forum Infect Dis. 2018 Nov 1;5(11):ofy236. doi: 10.1093/ofid/ofy236. eCollection 2018 Nov.

3.

Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment.

Galindo Bedor DC, Tavares Cavalcanti Bedor NC, Viturino da Silva JW, Damasceno Sousa G, Pereira de Santana D, Garcia-Bournissen F, Altcheh J, Blum B, Alves F, Ribeiro I.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00845-18. doi: 10.1128/AAC.00845-18. Print 2018 Dec.

4.

Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.

Gulin JEN, Bisio M, Rocco DM, Altcheh J, Solana ME, García-Bournissen F.

Exp Parasitol. 2018 Mar;186:50-58. doi: 10.1016/j.exppara.2018.02.002. Epub 2018 Feb 13.

PMID:
29448038
5.

Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.

Mucci J, Carmona SJ, Volcovich R, Altcheh J, Bracamonte E, Marco JD, Nielsen M, Buscaglia CA, Agüero F.

PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005972. doi: 10.1371/journal.pntd.0005972. eCollection 2017 Oct.

6.

The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.

Balouz V, Melli LJ, Volcovich R, Moscatelli G, Moroni S, González N, Ballering G, Bisio M, Ciocchini AE, Buscaglia CA, Altcheh J.

J Clin Microbiol. 2017 Dec;55(12):3444-3453. doi: 10.1128/JCM.01317-17. Epub 2017 Oct 4.

7.

Secretome analysis of Trypanosoma cruzi by proteomics studies.

Brossas JY, Gulin JEN, Bisio MMC, Chapelle M, Marinach-Patrice C, Bordessoules M, Palazon Ruiz G, Vion J, Paris L, Altcheh J, Mazier D.

PLoS One. 2017 Oct 3;12(10):e0185504. doi: 10.1371/journal.pone.0185504. eCollection 2017.

8.

Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): A potential novel tool for the detection of congenital Chagas infection.

Rivero R, Bisio M, Velázquez EB, Esteva MI, Scollo K, González NL, Altcheh J, Ruiz AM.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):26-28. doi: 10.1016/j.diagmicrobio.2017.06.012. Epub 2017 Jun 19.

PMID:
28684052
9.

Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study.

Moroni S, Moscatelli G, Bournissen FG, González N, Ballering G, Freilij H, Salgueiro F, Altcheh J.

PLoS One. 2016 Sep 2;11(9):e0160472. doi: 10.1371/journal.pone.0160472. eCollection 2016.

10.

[Publication of abstracts presented at the National Pediatric Research Meetings of the Argentine Society of Pediatrics: Related factors].

Domínguez P, Ossorio MF, Cuestas E, Giglio N, Grandi C, García-Bournissen F, Vidaurreta S, Altcheh J, Ferrero F.

Arch Argent Pediatr. 2016 Aug 1;114(4):351-4. doi: 10.5546/aap.2016.eng.351. Epub 2016 Jul 7. English, Spanish.

11.

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.

Fernández ML, Marson ME, Ramirez JC, Mastrantonio G, Schijman AG, Altcheh J, Riarte AR, Bournissen FG.

Mem Inst Oswaldo Cruz. 2016 Mar;111(3):218-21. doi: 10.1590/0074-02760150401. Epub 2016 Mar 15.

12.

Electrochemical magnetic microbeads-based biosensor for point-of-care serodiagnosis of infectious diseases.

Cortina ME, Melli LJ, Roberti M, Mass M, Longinotti G, Tropea S, Lloret P, Serantes DAR, Salomón F, Lloret M, Caillava AJ, Restuccia S, Altcheh J, Buscaglia CA, Malatto L, Ugalde JE, Fraigi L, Moina C, Ybarra G, Ciocchini AE, Comerci DJ.

Biosens Bioelectron. 2016 Jun 15;80:24-33. doi: 10.1016/j.bios.2016.01.021. Epub 2016 Jan 14.

PMID:
26802749
13.

[Guiding the etiological treatment of Chagas disease].

Sosa Estani S, Altcheh J, Riarte A, Freilij H, Fernandez M, Lloveras S, Pereiro A, Castellano LG, Salvatella R, Nicholls RS; Grupo de Trabajo.

Medicina (B Aires). 2015;75(4):270-1. Spanish. No abstract available.

14.

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina.

Moscatelli G, Berenstein A, Tarlovsky A, Siniawski S, Biancardi M, Ballering G, Moroni S, Schwarcz M, Hernández S, García-Bournissen F, Cozzi AE, Freilij H, Altcheh J.

Mem Inst Oswaldo Cruz. 2015 Aug;110(5):644-8. doi: 10.1590/0074-02760150107. Epub 2015 Jul 24.

15.

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.

Porrás AI, Yadon ZE, Altcheh J, Britto C, Chaves GC, Flevaud L, Martins-Filho OA, Ribeiro I, Schijman AG, Shikanai-Yasuda MA, Sosa-Estani S, Stobbaerts E, Zicker F.

PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun. No abstract available.

16.

Prevention of congenital Chagas through treatment of girls and women of childbearing age.

Moscatelli G, Moroni S, García-Bournissen F, Ballering G, Bisio M, Freilij H, Altcheh J.

Mem Inst Oswaldo Cruz. 2015 Jun;110(4):507-9. doi: 10.1590/0074-02760140347. Epub 2015 May 15.

17.

Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants.

Carmona SJ, Nielsen M, Schafer-Nielsen C, Mucci J, Altcheh J, Balouz V, Tekiel V, Frasch AC, Campetella O, Buscaglia CA, Agüero F.

Mol Cell Proteomics. 2015 Jul;14(7):1871-84. doi: 10.1074/mcp.M114.045906. Epub 2015 Apr 28.

18.

[Intestinal occlusion due to ascariasis].

Moscatelli G, Orbe G, Etchepareborda N, Altcheh J.

Arch Argent Pediatr. 2015 Jan;113(1):88-9. doi: 10.1590/S0325-00752015000100024. Spanish. No abstract available.

19.

Seroprevalence of Triatoma virus (Dicistroviridae: Cripaviridae) antibodies in Chagas disease patients.

Querido JF, Echeverría MG, Marti GA, Costa RM, Susevich ML, Rabinovich JE, Copa A, Montaño NA, Garcia L, Cordova M, Torrico F, Sánchez-Eugenia R, Sánchez-Magraner L, Muñiz-Trabudua X, López-Marijuan I, Rozas-Dennis GS, Diosque P, de Castro AM, Robello C, Rodríguez JS, Altcheh J, Salazar-Schettino PM, Bucio MI, Espinoza B, Guérin DM, Silva MS.

Parasit Vectors. 2015 Jan 17;8:29. doi: 10.1186/s13071-015-0632-9.

20.

Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.

Balouz V, Cámara Mde L, Cánepa GE, Carmona SJ, Volcovich R, Gonzalez N, Altcheh J, Agüero F, Buscaglia CA.

Clin Vaccine Immunol. 2015 Mar;22(3):304-12. doi: 10.1128/CVI.00684-14. Epub 2015 Jan 14.

21.

Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.

García-Bournissen F, Moroni S, Marson ME, Moscatelli G, Mastrantonio G, Bisio M, Cornou L, Ballering G, Altcheh J.

Arch Dis Child. 2015 Jan;100(1):90-4. doi: 10.1136/archdischild-2014-306358. Epub 2014 Sep 10.

PMID:
25210104
22.

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.

Altcheh J, Moscatelli G, Mastrantonio G, Moroni S, Giglio N, Marson ME, Ballering G, Bisio M, Koren G, García-Bournissen F.

PLoS Negl Trop Dis. 2014 May 22;8(5):e2907. doi: 10.1371/journal.pntd.0002907. eCollection 2014 May.

23.

Studying neglected diseases in children: antiserum for Indian red scorpion envenomation.

Garcia-Bournissen F, Gonzalez N, Altcheh J.

Arch Dis Child. 2014 Jun;99(6):568-9. doi: 10.1136/archdischild-2014-306077. Epub 2014 Apr 8. No abstract available.

PMID:
24713409
24.

Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole.

Marson ME, Altcheh J, Moscatelli G, Moroni S, García-Bournissen F, Mastrantonio GE.

Eur J Drug Metab Pharmacokinet. 2015 Jun;40(2):209-17. doi: 10.1007/s13318-014-0195-8. Epub 2014 Apr 8.

PMID:
24711214
25.

Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants?

Lorenzetti MA, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV.

Clin Microbiol Infect. 2014 Nov;20(11):O861-9. doi: 10.1111/1469-0691.12631. Epub 2014 May 15.

26.

Neurotrichinosis in a pediatric patient.

Moscatelli G, Sordelli N, Moroni S, De Mena A, Gabriela M, Bournissen Facundo G, Jaime A.

Pediatr Infect Dis J. 2014 Jan;33(1):115-7. doi: 10.1097/INF.0000000000000072. No abstract available. Erratum in: Pediatr Infect Dis J. 2014 Feb;33(2):151. Nora, Sordelli [corrected to Sordelli, Nora]; Arturo, De Mena [corrected to De Mena, Arturo]; Altcheh, Jaime [corrected to Jaime, Altcheh].

PMID:
24346603
27.

Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.

Marsón ME, Dana DD, Altcheh J, García-Bournissen F, Mastrantonio G.

J Clin Lab Anal. 2013 Sep;27(5):384-90. doi: 10.1002/jcla.21615.

PMID:
24038224
28.

Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS.

Bisio M, Altcheh J, Lattner J, Moscatelli G, Fink V, Burgos JM, Bournissen FG, Schijman AG, Freilij H.

Emerg Infect Dis. 2013;19(9):1490-2. doi: 10.3201/eid1909.130667.

29.

Impact of migration on the occurrence of new cases of Chagas disease in Buenos Aires city, Argentina.

Moscatelli G, García Bournissen F, Freilij H, Berenstein A, Tarlovsky A, Moroni S, Ballering G, Biancardi M, Siniawski S, Schwarcz M, Hernández S, Espejo Cozzi A, Altcheh J.

J Infect Dev Ctries. 2013 Aug 15;7(8):635-7. doi: 10.3855/jidc.2930. No abstract available.

30.

A five-year-old child with renal hydatidosis.

Moscatelli G, Moroni S, Freilij H, Salgueiro F, García Bournissen F, Altcheh J.

Am J Trop Med Hyg. 2013 Sep;89(3):554-6. doi: 10.4269/ajtmh.13-0243. Epub 2013 Jul 29.

31.

A simple and efficient HPLC method for benznidazole dosage in human breast milk.

Marson ME, Padró JM, Reta MR, Altcheh J, García-Bournissen F, Mastrantonio G.

Ther Drug Monit. 2013 Aug;35(4):522-6. doi: 10.1097/FTD.0b013e31828f5214.

PMID:
23851912
32.

Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma.

Padró JM, Marsón ME, Mastrantonio GE, Altcheh J, García-Bournissen F, Reta M.

Talanta. 2013 Mar 30;107:95-102. doi: 10.1016/j.talanta.2012.12.050. Epub 2013 Jan 5.

PMID:
23598198
33.

LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in Argentina.

Gantuz M, Lorenzetti MA, Altcheh J, De Matteo E, Moscatelli G, Moroni S, Chabay PA, Preciado MV.

Infect Genet Evol. 2013 Mar;14:275-81. doi: 10.1016/j.meegid.2012.12.025. Epub 2013 Jan 8.

PMID:
23305886
34.

Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.

Gulin JE, Eagleson MA, Postan M, Cutrullis RA, Freilij H, Bournissen FG, Petray PB, Altcheh J.

J Antimicrob Chemother. 2013 Apr;68(4):888-94. doi: 10.1093/jac/dks478. Epub 2012 Dec 4.

PMID:
23212113
35.

[Pulmonary Hydatidosis].

Moscatelli G, Abraham Z, Moroni S, Martínez Iriart E, Rodríguez M, Mirón L, Vásquez Millán S, Casas L, Altcheh J.

Arch Argent Pediatr. 2012 May-Jun;110(3):265-7. doi: 10.1590/S0325-00752012000300018. Spanish. No abstract available.

36.

Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina.

Cura CI, Lucero RH, Bisio M, Oshiro E, Formichelli LB, Burgos JM, Lejona S, Brusés BL, Hernández DO, Severini GV, Velazquez E, Duffy T, Anchart E, Lattes R, Altcheh J, Freilij H, Diez M, Nagel C, Vigliano C, Favaloro L, Favaloro RR, Merino DE, Sosa-Estani S, Schijman AG.

Parasitology. 2012 Apr;139(4):516-21. doi: 10.1017/S0031182011002186. Epub 2012 Feb 6.

PMID:
22309735
37.

Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Lorenzetti MA, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV.

J Clin Microbiol. 2012 Mar;50(3):609-18. doi: 10.1128/JCM.05778-11. Epub 2012 Jan 11. Erratum in: J Clin Microbiol. 2012 Jul;50(7):2543.

38.

Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Cutrullis RA, Moscatelli GF, Moroni S, Volta BJ, Cardoni RL, Altcheh JM, Corral RS, Freilij HL, Petray PB.

PLoS One. 2011;6(10):e27133. doi: 10.1371/journal.pone.0027133. Epub 2011 Oct 31.

39.

Antitrypanosomal therapy for chronic Chagas' disease.

Garcia-Bournissen F, Altcheh J.

N Engl J Med. 2011 Sep 29;365(13):1258; author reply 1259. doi: 10.1056/NEJMc1108653. No abstract available.

PMID:
21991908
40.

Urbanization of congenital transmission of Trypanosoma cruzi: prospective polymerase chain reaction study in pregnancy.

Bisio M, Seidenstein ME, Burgos JM, Ballering G, Risso M, Pontoriero R, Moreau M, Altcheh J, Leguizamón MS, Freilij H, Marceillac M, Schijman AG.

Trans R Soc Trop Med Hyg. 2011 Oct;105(10):543-9. doi: 10.1016/j.trstmh.2011.07.003. Epub 2011 Jul 30.

PMID:
21803389
41.

Adverse events after the use of benznidazole in infants and children with Chagas disease.

Altcheh J, Moscatelli G, Moroni S, Garcia-Bournissen F, Freilij H.

Pediatrics. 2011 Jan;127(1):e212-8. doi: 10.1542/peds.2010-1172. Epub 2010 Dec 20.

PMID:
21173000
42.

[Neurocysticercosis: report of an autochthonous case in Buenos Aires city].

Moroni S, Moscatelli G, Freilij H, Altcheh J.

Arch Argent Pediatr. 2010 Dec;108(6):e143-6. doi: 10.1590/S0325-00752010000600018. Spanish.

43.

Congenital infections with Trypanosoma cruzi or Toxoplasma gondii are associated with decreased serum concentrations of interferon-γ and interleukin-18 but increased concentrations of interleukin-10.

Mayer JP, Biancardi M, Altcheh J, Freilij H, Weinke T, Liesenfeld O.

Ann Trop Med Parasitol. 2010 Sep;104(6):485-92. doi: 10.1179/136485910X12786389891362.

PMID:
20863437
44.

EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants.

Lorenzetti MA, Altcheh J, Moroni S, Moscatelli G, Chabay PA, Preciado MV.

J Med Virol. 2010 Oct;82(10):1730-8. doi: 10.1002/jmv.21871.

PMID:
20827771
45.

[Chagas disease, 100 years after its identification].

Altcheh J.

Arch Argent Pediatr. 2010 Feb;108(1):4-5. doi: 10.1590/S0325-00752010000100002. Spanish. No abstract available.

46.

Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis.

Garcia-Bournissen F, Altcheh J, Panchaud A, Ito S.

Arch Dis Child. 2010 Mar;95(3):224-8. doi: 10.1136/adc.2008.157297. Epub 2009 Nov 29.

PMID:
19948512
47.

Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas.

Lorenzetti MA, Gutiérrez MI, Altcheh J, Moscatelli G, Moroni S, Chabay PA, Preciado MV.

J Med Virol. 2009 Nov;81(11):1912-7. doi: 10.1002/jmv.21616. Erratum in: J Med Virol. 2012 Oct;84(10):1697.

PMID:
19774688
48.

Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery.

Burgos JM, Altcheh J, Petrucelli N, Bisio M, Levin MJ, Freilij H, Schijman AG.

Diagn Microbiol Infect Dis. 2009 Sep;65(1):58-61. doi: 10.1016/j.diagmicrobio.2009.04.010.

PMID:
19679236
49.

Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients.

Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H, Schijman AG.

PLoS Negl Trop Dis. 2009;3(4):e419. doi: 10.1371/journal.pntd.0000419. Epub 2009 Apr 21.

50.

Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.

Garcia-Bournissen F, Altcheh J, Giglio N, Mastrantonio G, Della Védova CO, Koren G.

Paediatr Drugs. 2009;11(1):33-7. Review.

PMID:
19127950

Supplemental Content

Loading ...
Support Center